Abstract

Background and aims: Quantifying placebo rates and the factors influencing them are essential to inform trial design. We provide a contemporary summary of clinical, endoscopic, histological and safety placebo rates in induction and maintenance clinical trials of ulcerative colitis, and identify factors influencing them.

Tags

Clinical Trials, Drug Therapy, Placebo, Ulcerative Colitis, therapeutic use, Immunosuppressive Agents

Read More